Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Hims & Hers Health, Inc. (HIMS)

NYQ · Drug Manufacturers - Specialty & Generic

$29.32-0.92 (-3.04%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$6.79B
P/E (TTM)
EPS
$-0.09
Div Yield
52W Range
$13.74–$70.43
Beta
2.34

Company overview

Next earnings: 2026-08-10(13d)

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

Hims & Hers Health, Inc. has not issued a press release in this window.

SEC filings

All filings →

Hims & Hers Health, Inc. has not filed an SEC document in this window.

Hims & Hers Health, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
14,322,912 sh-23.7%
26,573,504 sh+5.7%
20,925,666 sh+7.2%
16,900,039 sh+0.0%
18,838,270 sh+5.9%
4,818,009 sh-47.0%
13,075,110 sh+1.6%
3,929,232 sh-46.0%

People at Hims & Hers Health, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$9.6M
NI -$7.7M
06/25
$8.0M
NI $42.5M
09/25
$599.0M
NI $15.8M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.06
Prior: $0.17
Revenue sparkline